168 related articles for article (PubMed ID: 10599371)
1. Mucocutaneous side effects and continuation of aurotherapy in patients with rheumatoid arthritis.
Taukumova LA; Mouravjoy YuV ; Gribakin SG
Adv Exp Med Biol; 1999; 455():367-73. PubMed ID: 10599371
[TBL] [Abstract][Full Text] [Related]
2. Skin rashes and stomatitis due to parenteral treatment of rheumatoid arthritis with sodium aurothiomalate.
Svensson A; Theander J
Ann Rheum Dis; 1992 Mar; 51(3):326-9. PubMed ID: 1533505
[TBL] [Abstract][Full Text] [Related]
3. [Side effects of gold salt therapy in patients with rheumatoid arthritis].
Vlak T; Jajić I
Reumatizam; 1992; 39(2):25-8. PubMed ID: 1366149
[TBL] [Abstract][Full Text] [Related]
4. Nickel contamination of gold salts: link with gold-induced skin rash.
Choy EH; Gambling L; Best SL; Jenkins RE; Kondeatis E; Vaughan R; Black MM; Sadler PJ; Panayi GS
Br J Rheumatol; 1997 Oct; 36(10):1054-8. PubMed ID: 9374921
[TBL] [Abstract][Full Text] [Related]
5. [The Tauredon treatment of rheumatoid arthritis patients: its efficacy and tolerance when used long term].
Murav'ev IuV; Nasonova VA; Ivanova MM; Taukumova LA
Ter Arkh; 1996; 68(5):16-8. PubMed ID: 9082589
[No Abstract] [Full Text] [Related]
6. [Multicenter double-blind comparison of auranofin and Tauredon].
Kaik B; Bröll H
Wien Klin Wochenschr Suppl; 1984; 156():33-40. PubMed ID: 6442055
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of efficacy and safety of multiple intravenous infusion of anti-tumor necrosis factor-alpha monoclonal antibody (Remicade) combined with methotrexate compared with sodium aurothiomalate and intramuscular depot methylprednisolone in rheumatoid arthritis].
Wiland P; Głowska A; Chlebicki A; Szechiński J
Pol Arch Med Wewn; 2002 Nov; 108(5):1055-63. PubMed ID: 12685246
[TBL] [Abstract][Full Text] [Related]
8. Reinstitution of gold therapy in rheumatoid arthritis after mucocutaneous reactions.
Klinefelter
J Rheumatol; 1975 Mar; 2(1):21-7. PubMed ID: 127042
[TBL] [Abstract][Full Text] [Related]
9. Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate.
Rodriguez-Pérez M; González-Dominguez J; Matarán L; Garcia-Pérez S; Salvatierra D
J Rheumatol; 1994 Jan; 21(1):41-3. PubMed ID: 8151585
[TBL] [Abstract][Full Text] [Related]
10. [The effect of gold salts on rheumatoid factor dynamics in patients with rheumatoid arthritis].
Vlak T; Jajić I
Reumatizam; 1992; 39(1):11-3. PubMed ID: 1366138
[TBL] [Abstract][Full Text] [Related]
11. Injectable gold-induced hepatitis and neutropenia in rheumatoid arthritis.
Uhm WS; Yoo DH; Lee JH; Kim TH; Jun JB; Lee IH; Bae SC; Kim SY
Korean J Intern Med; 2000 Jul; 15(2):156-9. PubMed ID: 10992732
[TBL] [Abstract][Full Text] [Related]
12. A 10 year follow up of parenteral gold therapy in patients with rheumatoid arthritis.
Bendix G; Bjelle A
Ann Rheum Dis; 1996 Mar; 55(3):169-76. PubMed ID: 8712879
[TBL] [Abstract][Full Text] [Related]
13. [The effect of Tauredon on the development of non-specific indicators of inflammatory activity in patients with rheumatoid arthritis].
Vlak T; Jajić Z
Reumatizam; 1992; 39(1):19-22. PubMed ID: 1366140
[TBL] [Abstract][Full Text] [Related]
14. [Complement (C3 and C4) in patients with rheumatoid arthritis during 6 months of treatment with gold salts].
Vlak T; Jajić I
Reumatizam; 1992; 39(1):7-10. PubMed ID: 1366144
[TBL] [Abstract][Full Text] [Related]
15. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
[TBL] [Abstract][Full Text] [Related]
16. Prospective six year follow up of patients withdrawn from a randomised study comparing parenteral gold salt and methotrexate.
Sander O; Herborn G; Bock E; Rau R
Ann Rheum Dis; 1999 May; 58(5):281-7. PubMed ID: 10225812
[TBL] [Abstract][Full Text] [Related]
17. Long term chrysotherapy: incidence of toxicity and efficacy during sequential time periods.
Kean WF; Anastassiades TP
Arthritis Rheum; 1979 May; 22(5):495-501. PubMed ID: 156026
[TBL] [Abstract][Full Text] [Related]
18. Mucocutaneous toxicity of gold salts by parenteral administration--rechallenge with auranofin.
Tumiati B; Veneziani M; Bellelli A; Portioli I
J Rheumatol; 1987 Feb; 14(1):177. PubMed ID: 2952794
[No Abstract] [Full Text] [Related]
19. [Parenteral gold therapy (Tauredon) in chronic polyarthritis].
Tausch G; Gaismayer K
Wien Klin Wochenschr Suppl; 1984; 156():19-21. PubMed ID: 6442051
[TBL] [Abstract][Full Text] [Related]
20. Comparative toxicity of gold preparations in treatment of rheumatoid arthritis.
Lawrence JS
Ann Rheum Dis; 1976 Apr; 35(2):171-3. PubMed ID: 821403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
